INFLUENCE OF CYP3A5*3 AND ABCB1 POLYMORPHISMS ON CHRONIC DAMAGE IN KIDNEY PROTOCOL BIOPSIES

被引：0
|
作者：
Vidal, Anna [1 ]
Fontova, Pere [2 ]
Elens, Laure [3 ]
Hesselink, Dennis A. [4 ]
vanSchaik, Ron [4 ]
vanGelder, Teun [4 ]
Bestard, Oriol [2 ]
Melilli, Edoardo [2 ]
Montero, Nuria [2 ]
Cerezo, Gema [2 ]
Torras, Joan [2 ]
Cruzado, Josep M. [2 ]
Grinyo, Josep M. [2 ]
Lloberas, Nuria [5 ]
机构：
[1] Univ Barcelona, Idibell, Barcelona, Spain
[2] Hosp Bellvitge IDIBELL, Barcelona, Spain
[3] Catholic Univ Louvain, Louvain La Neuve, Belgium
[4] Erasmus Med Hosp, Rotterdam, Netherlands
[5] Hosp Bellvitge Princeps Espanya, Barcelona, Spain
来源：
TRANSPLANT INTERNATIONAL | 2019年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
OS199
引用
收藏
页码：61 / 61
页数：1
相关论文
共 50 条
  • [21] Influence of CYP3A5 and MDR1(ABCB1) Polymorphisms on the Pharmacokinetics of Tacrolimus in Chinese Renal Transplant Recipients
    Rong, G.
    Jing, L.
    Deng-Qing, L.
    Hong-Shan, Z.
    Shai-Hong, Z.
    Xin-Min, N.
    TRANSPLANTATION PROCEEDINGS, 2010, 42 (09) : 3455 - 3458
  • [22] EFFECTS OF POLYMORPHIMS OF CYP3A5 AND ABCB1 GENES ON CHRONIC NEPHROPATHY: COHORT STUDY
    Rojas, L.
    Herrero, M. J.
    Boso, V
    Poveda, J. L.
    Alino, S. F.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2013, 113 : 23 - 24
  • [23] The CYP3A5 and ABCB1 Gene Polymorphisms in Kidney Transplant Patients and Establishment of Initial Daily Tacrolimus Dosing Formula
    He, Yuting
    Ma, Yixiao
    Fu, Qian
    Liang, Jianbo
    Yu, Xuegao
    Huang, Hao
    Zhong, Liangying
    Huang, Bin
    ANNALS OF PHARMACOTHERAPY, 2022, 56 (04) : 393 - 400
  • [24] CYP3A5 and ABCB1 Polymorphisms as Predictors for Sunitinib Outcome in Metastatic Renal Cell Carcinoma
    Diekstra, Meta H. M.
    Swen, Jesse J.
    Boven, Epie
    Castellano, Daniel
    Gelderblom, Hans
    Mathijssen, Ron H. J.
    Rodriguez-Antona, Cristina
    Garcia-Donas, Jesus
    Rini, Brian I.
    Guchelaar, Henk-Jan
    EUROPEAN UROLOGY, 2015, 68 (04) : 621 - 629
  • [25] CYP3A5 and CYP3A4, but not ABCB1 polymorphisms affect tacrolimus dose-adjusted trough concentrations in kidney transplant recipients
    Kurzawski, Mateusz
    Dabrowska, Justyna
    Dziewanowski, Krzysztof
    Domanski, Leszek
    Peruzynska, Magdalena
    Drozdzik, Marek
    PHARMACOGENOMICS, 2014, 15 (02) : 179 - 188
  • [26] Association of CYP2C8, CYP3A4, CYP3A5, and ABCB1 polymorphisms with the pharmacokinetics of paclitaxel
    Henningsson, A
    Marsh, S
    Loos, WJ
    Karlsson, MO
    Garsa, A
    Mross, K
    Mielke, S
    Viganò, L
    Locatelli, A
    Verweij, J
    Sparreboom, A
    McLeod, HL
    CLINICAL CANCER RESEARCH, 2005, 11 (22) : 8097 - 8104
  • [27] Influence of CYP2D6, CYP3A4, CYP3A5 and ABCB1 Polymorphisms on Pharmacokinetics and Safety of Aripiprazole in Healthy Volunteers
    Belmonte, Carmen
    Ochoa, Dolores
    Roman, Manuel
    Saiz-Rodriguez, Miriam
    Wojnicz, Aneta
    Isabel Gomez-Sanchez, Clara
    Martin-Vilchez, Samuel
    Abad-Santos, Francisco
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 122 (06) : 596 - 605
  • [28] Influence of ABCB1, CYP3A4*18B and CYP3A5*3 polymorphisms on cyclosporine A pharmacokinetics in bone marrow transplant recipients
    Feng Qiu
    Xiao-Jing He
    Ya-Xin Sun
    Jesse Li-Ling
    Li-Mei Zhao
    Pharmacological Reports, 2011, 63 : 815 - 825
  • [29] Frequency of ABCB1 C3435T and CYP3A5*3 Genetic Polymorphisms in the Lebanese Population
    Milane, Aline
    Khazen, Georges
    Olaywan, Layal
    Zarzour, Fatima
    Mohty, Razan
    Sarkis, Aline
    Zalloua, Pierre
    Barbari, Antoine
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2021, 19 (05) : 434 - 438
  • [30] EFFECT OF CYP3A5, CYP3A4, POR AND ABCB1 POLYMORPHISMS ON TACROLIMUS METABOLISM IN RENAL TRANSPLANT PATIENTS
    Chong, Winnie
    Hamilton-Jones, Siobhan
    Kim, Jon Jin
    Navarrete, Cristina V.
    Key, Tim
    Howell, Martin W.
    HLA, 2020, 95 (04) : 316 - 316
12345